Mealey's (September 9, 2020, 10:14 AM EDT) -- PHILADELPHIA — Citing the common-law presumption of public access, the Pennsylvania federal judge presiding over the Avandia multidistrict litigation on Sept. 3 mostly denied a motion by GlaxoSmithKline LLC (GSK) to continue sealing expert reports that were subject to a 2008 discovery protective order in the long-running litigation, finding that the pharmaceutical firm did not establish that any injury would result in the documents being unsealed (In re: Avandia Marketing, Sales Practices and Products Liability Litigation, No. 07-1871, E.D. Pa., 2020 U.S. Dist. LEXIS 161614)....